|
[1]
|
Meng, Z., Moroishi, T. and Guan, K.L. (2016) Mechanisms of Hippo Pathway Regulation. Genes & Development, 30, 1-17. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Harvey, K.F., Zhang, X. and Thomas, D.M. (2013) The Hippo Pathway and Human Cancer. Nature Reviews Cancer, 13, 246-257. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Hansen, C.G., Moroishi, T. and Guan, K.L. (2015) YAP and TAZ: A Nexus for Hippo Signaling and Beyond. Trends in Cell Biology, 25, 499-513. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Misra, J.R. and Irvine, K.D. (2018) The Hippo Signaling Network and Its Biological Functions. Annual Review of Genetics, 52, 65-87. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Zhang, K., et al. (2015) YAP and TAZ Take Center Stage in Cancer. Biochemistry, 54, 6555-6566. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Totaro, A., Panciera, T. and Piccolo, S. (2018) YAP/TAZ Upstream Signals and Downstream Responses. Nature Cell Biology, 20, 888-899. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Santoro, R., et al. (2020) Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer. Molecular Cancer Therapeutics, 19, 247-257. [Google Scholar] [CrossRef]
|
|
[8]
|
Dolcet, X., et al. (2005) NF-κB in Development and Progression of Human Cancer. Virchows Archiv, 446, 475-482. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Zhao, L., et al. (2018) YAP1 Is Essential for Osteoclastogenesis through a TEADs-Dependent Mechanism. Bone, 110, 177-186. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Caire, R., et al. (2021) YAP/TAZ: Key Players for Rheumatoid Arthritis Severity by Driving Fibroblast like Synoviocytes Phenotype and Fibro-Inflammatory Response. Frontiers in Immunology, 12, Article ID: 791907. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Ye, S., et al. (2018) YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis. Cancer Research, 78, 2705-2720. [Google Scholar] [CrossRef]
|
|
[12]
|
Rivera-Reyes, A., et al. (2018) YAP1 Enhances NF-κB-Dependent and Independent Effects on Clock-Mediated Unfolded Protein Responses and Autophagy in Sarcoma. Cell Death & Disease, 9, 1108. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Wang, J., et al. (2019) YAP Promotes the Malignancy of Endometrial Cancer Cells via Regulation of IL-6 and IL-11. Molecular Medicine, 25, 32. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Zhao, T. and Wang, Z. (2022) HTLV-1 Activates YAP via NF-κB/p65 to Promote Oncogenesis. Proceedings of the National Academy of Sciences of the United States of America, 119, e2115316119. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Wang, Q., et al. (2018) REGγ Controls Hippo Signaling and Reciprocal NF-κB-YAP Regulation to Promote Colon Cancer. Clinical Cancer Research, 24, 2015-2025. [Google Scholar] [CrossRef]
|
|
[16]
|
Gao, Y., et al. (2017) TNFα-YAP/p65-HK2 Axis Mediates Breast Cancer Cell Migration. Oncogenesis, 6, e383. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Rohban, M.H. and Singh, S. (2017) Systematic Morphological Profiling of Human Gene and Allele Function via Cell Painting. eLife, 6, e24060. [Google Scholar] [CrossRef]
|
|
[18]
|
Yang, B., et al. (2020) YAP1 Inhibits the Induction of TNF-α-Stimulated Bone-Resorbing Mediators by Suppressing the NF-κB Signaling Pathway in MC3T3-E1 Cells. Journal of Cellular Physiology, 235, 4698-4708. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Lv, Y., et al. (2018) YAP Controls Endothelial Activation and Vascular Inflammation through TRAF6. Circulation Research, 123, 43-56. [Google Scholar] [CrossRef]
|
|
[20]
|
LaCanna, R., et al. (2019) Yap/Taz Regulate Alveolar Regeneration and Resolution of Lung Inflammation. Journal of Clinical Investigation, 129, 2107-2122. [Google Scholar] [CrossRef]
|
|
[21]
|
Zhang, Q., et al. (2018) Yes-Associated Protein (YAP) and Transcriptional Coactivator with PDZ-Binding Motif (TAZ) Mediate Cell Density-Dependent Proinflammatory Responses. Journal of Biological Chemistry, 293, 18071-18085. [Google Scholar] [CrossRef]
|
|
[22]
|
Tang, K.M., et al. (2021) Role of the Hippo-YAP/NF-κB Signaling Pathway Crosstalk in Regulating Biological Behaviors of Macrophages under Titanium Ion Exposure. Journal of Applied Toxicology, 41, 561-571. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Luo, X., et al. (2021) Hippo Pathway Counter-Regulates Innate Immunity in Hepatitis B Virus Infection. Frontiers in Immunology, 12, Article ID: 684424. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Wang, S., et al. (2020) The Crosstalk between Hippo-YAP Pathway and Innate Immunity. Frontiers in Immunology, 11, 323. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Caire, R., et al. (2022) YAP Transcriptional Activity Dictates Cell Response to TNF in Vitro. Frontiers in Immunology, 13, Article ID: 856247. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Yu, F., et al. (2021) Wnt/β-Catenin Signaling in Cancers and Targeted Therapies. Signal Transduction and Targeted Therapy, 6, 307. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Eisenmann, D.M. (2005) Wnt Signaling. WormBook. 1-17. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Li, N., Lu, N. and Xie, C. (2019) The Hippo and Wnt Signalling Pathways: Crosstalk during Neoplastic Progression in Gastrointestinal Tissue. FEBS Journal, 286, 3745-3756. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Quinn, H.M., Vogel, R. and Popp, O. (2021) YAP and β-Catenin Cooperate to Drive Oncogenesis in Basal Breast Cancer. Cancer Research, 81, 2116-2127. [Google Scholar] [CrossRef]
|
|
[30]
|
Wang, Y., et al. (2017) β-Catenin-Mediated YAP Signaling Promotes Human Glioma Growth. Journal of Experimental & Clinical Cancer Research, 36, 136. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Tang, X., et al. (2019) Knockdown of YAP Inhibits Growth in Hep-2 Laryngeal Cancer Cells via Epithelial-Mesenchymal Transition and the Wnt/β-Catenin Pathway. BMC Cancer, 19, Article No. 654. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Zeng, M., et al. (2021) CBX2 Depletion Inhibits the Proliferation, Invasion and Migration of Gastric Cancer Cells by Inactivating the YAP/β-Catenin Pathway. Molecular Medicine Reports, 23, 137. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Deng, F., et al. (2018) YAP Triggers the Wnt/β-Catenin Signalling Pathway and Promotes Enterocyte Self-Renewal, Regeneration and Tumorigenesis after DSS-Induced Injury. Cell Death & Disease, 9, 153. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Wang, S., et al. (2019) LKB1 and YAP Phosphorylation Play Important Roles in Celastrol-Induced β-Catenin Degradation in Colorectal Cancer. Therapeutic Advances in Medical Oncology, 11, 1-19. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Liu, T., et al. (2019) The β-Catenin/YAP Signaling Axis Is a Key Regulator of Melanoma-Associated Fibroblasts. Signal Transduction and Targeted Therapy, 4, 63. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Bisso, A., et al. (2020) Cooperation between MYC and β-Catenin in Liver Tumorigenesis Requires Yap/Taz. Hepatology, 72, 1430-1443. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Konsavage, W.M., et al. (2012) Wnt/β-Catenin Signaling Regulates Yes-Associated Protein (YAP) Gene Expression in Colorectal Carcinoma Cells. Journal of Biological Chemistry, 287, 11730-11739. [Google Scholar] [CrossRef]
|
|
[38]
|
Rosenbluh, J., et al. (2012) β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis. Cell, 151, 1457-1473. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Chen, C., et al. (2018) YAP-Dependent Ubiquitination and Degradation of β-Catenin Mediates Inhibition of Wnt Signalling Induced by Physalin F in Colorectal Cancer. Cell Death & Disease, 9, 591. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Azzolin, L., et al. (2014) YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response. Cell, 158, 157-170. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Massagué, J. (2008) TGFbeta in Cancer. Cell, 134, 215-230. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Ferrigno, O., et al. (2002) Yes-Associated Protein (YAP65) Interacts with Smad7 and Potentiates Its Inhibitory Activity against TGF-Beta/Smad Signaling. Oncogene, 21, 4879-4884. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Hiemer, S.E., Szymaniak, A.D. and Varelas, X. (2014) The Transcriptional Regulators TAZ and YAP Direct Transforming Growth Factor β-Induced Tumorigenic Phenotypes in Breast Cancer Cells. Journal of Biological Chemistry, 289, 13461-13474. [Google Scholar] [CrossRef]
|
|
[44]
|
Yan, X., He, Y. and Yang, S. (2022) A Positive Feedback Loop: RAD18-YAP-TGF-β between Triple-Negative Breast Cancer and Macrophages Regulates Cancer Stemness and Progression. Cell Death Discovery, 8, Article No. 196. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Du, X.X., et al. (2021) YAP/STAT3 Promotes the Immune Escape of Larynx Carcinoma by Activating VEGFR1-TGFβ Signaling to Facilitate PD-L1 Expression in M2-Like TAMs. Experimental Cell Research, 405, Article ID: 112655. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Sun, Q., et al. (2021) 25(OH)-Vitamin D Alleviates Neonatal Infectious Pneumonia via Regulating TGFβ-Mediated Nuclear Translocation Mechanism of YAP/TAZ. Bioengineered, 12, 8931-8942. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Ye, S., Liu, Y. and Fuller, A.M. (2020) TGFβ and Hippo Pathways Cooperate to Enhance Sarcomagenesis and Metastasis through the Hyaluronan-Mediated Motility Receptor (HMMR). Molecular Cancer Research, 18, 560-573. [Google Scholar] [CrossRef]
|
|
[48]
|
Qi, Y.J., et al. (2020) Porphyromonas gingivalis Promotes Progression of Esophageal Squamous Cell Cancer via TGFβ-Dependent Smad/YAP/TAZ Signaling. PLOS Biology, 18, e3000825. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Fujii, M., et al. (2012) TGF-β Synergizes with Defects in the Hippo Pathway to Stimulate Human Malignant Mesothelioma Growth. Journal of Experimental Medicine, 209, 479-494. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Zhuang, C., et al. (2020) Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk between Hippo/Yap and TGF-β/Smad Signaling. Frontiers in Molecular Biosciences, 7, Article ID: 616768. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Lüönd, F. and Pirkl, M. (2022) Hierarchy of TGFβ/SMAD, Hippo/YAP/TAZ, and Wnt/β-Catenin Signaling in Melanoma Phenotype Switching. Life Science Alliance, 5, e202101010. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Sun, J.G., et al. (2016) Yap1 Promotes the Survival and Self-Renewal of Breast Tumor Initiating Cells via Inhibiting Smad3 Signaling. Oncotarget, 7, 9692-706. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Chen, C.L., et al. (2013) Reciprocal Regulation by TLR4 and TGF-β in Tumor-Initiating Stem-Like Cells. Journal of Clinical Investigation, 123, 2832-2849. [Google Scholar] [CrossRef]
|
|
[54]
|
Zhang, T., et al. (2014) Ellagic Acid Exerts Anti-Proliferation Effects via Modulation of Tgf-β/Smad3 Signaling in MCF-7 Breast Cancer Cells. Asian Pacific Journal of Cancer Prevention, 15, 273-276. [Google Scholar] [CrossRef]
|
|
[55]
|
Kumar, K.J., et al. (2015) Antrodin C Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer Cells via Suppression of Smad2/3 and β-Catenin Signaling Pathways. PLOS ONE, 10, e0117111. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Labibi, B., et al. (2020) Modeling the Control of TGF-β/Smad Nuclear Accumulation by the Hippo Pathway Effectors, Taz/Yap. iScience, 23, Article ID: 101416. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Fernandez, L.A., et al. (2012) Oncogenic YAP Promotes Radioresistance and Genomic Instability in Medulloblastoma through IGF2-Mediated Akt Activation. Oncogene, 31, 1923-1937. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Jeong, S.H., et al. (2018) Hippo-Mediated Suppression of IRS2/AKT Signaling Prevents Hepatic Steatosis and Liver Cancer. Journal of Clinical Investigation, 128, 1010-1025. [Google Scholar] [CrossRef]
|
|
[59]
|
Koo, J.H. and Plouffe, S.W. (2020) Induction of AP-1 by YAP/TAZ Contributes to Cell Proliferation and Organ Growth. Genes & Development, 34, 72-86. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
He, L., Pratt, H. and Gao, M. (2021) YAP and TAZ Are Transcriptional Co-Activators of AP-1 Proteins and STAT3 during Breast Cellular Transformation. eLife, 10, e67312. [Google Scholar] [CrossRef]
|
|
[61]
|
Slemmons, K.K., et al. (2017) A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma. Molecular Cancer Research, 15, 1777-1791. [Google Scholar] [CrossRef]
|
|
[62]
|
Chan, L.H., et al. (2014) Hedgehog Signaling Induces Osteosarcoma Development through Yap1 and H19 Overexpression. Oncogene, 33, 4857-4866. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Tariki, M., et al. (2014) The Yes-Associated Protein Controls the Cell Density Regulation of Hedgehog Signaling. Oncogenesis, 3, e112. [Google Scholar] [CrossRef] [PubMed]
|